Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Lab Costs: Found Health's terms state that laboratory services are not part of the subscription fee
Toujeo (Insulin Glargine) Toujeo 2022 sales: $1.225 billion Company/Developer: Sanofi Date of first FDA approval: February 25, 2015 Indications Toujeo is FDA-approved for: Toujeo is a long-acting human insulin analog prescribed to enhance glycemic control in adults and pediatric patients aged six years and older with diabetes mellitus
Add it gradually so it does not cause bloating
This creates a powerful record of due diligence
Stop the Cost Spiral and Drive Better Outcomes You shouldnt have to choose between coverage and losing control of your pharmacy spend
US$ 24.35
US$ 27.47
US$ 21.44
US$ 23.65
US$ 24.59
